• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens.

作者信息

Bergstresser P R, Elewski B, Hanifin J, Lesher J, Savin R, Shupack J, Stiller M, Tschen E, Zaias N, Birnbaum J E

机构信息

University of Texas, Southwestern Medical Center, Dallas.

出版信息

J Am Acad Dermatol. 1993 Apr;28(4):648-51. doi: 10.1016/s0190-9622(08)81787-2.

DOI:10.1016/s0190-9622(08)81787-2
PMID:8463471
Abstract
摘要

相似文献

1
Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens.外用特比萘芬和克霉唑治疗足趾间足癣：1周和4周治疗方案的治愈率和复发率的多中心比较
J Am Acad Dermatol. 1993 Apr;28(4):648-51. doi: 10.1016/s0190-9622(08)81787-2.
2
Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazole.特比萘芬或克霉唑治疗足趾间足癣患者的长期预后
J Am Acad Dermatol. 1995 Feb;32(2 Pt 1):290-2. doi: 10.1016/0190-9622(95)90153-1.
3
Topical treatment of interdigital tinea pedis: terbinafine compared with clotrimazole.足趾间足癣的局部治疗：特比萘芬与克霉唑的比较
Australas J Dermatol. 1999 Nov;40(4):197-200. doi: 10.1046/j.1440-0960.1999.00360.x.
4
Tinea pedis: clinical experience and efficacy of short treatment.足癣：短期治疗的临床经验与疗效
Dermatology. 1997;194 Suppl 1:3-6. doi: 10.1159/000246173.
5
Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial.1%特比萘芬外用溶液使用1周与1%克霉唑外用溶液使用4周治疗足趾间足癣的疗效和耐受性比较：一项随机、双盲、多中心、8周临床试验
Mycoses. 1999;42(5-6):415-20. doi: 10.1046/j.1439-0507.1999.00477.x.
6
Comparison of terbinafine and clotrimazole in treating tinea pedis.特比萘芬与克霉唑治疗足癣的比较。
BMJ. 1993 Sep 11;307(6905):645-7. doi: 10.1136/bmj.307.6905.645.
7
Comparison of one week of oral terbinafine (250 mg/day) with four weeks of treatment with clotrimazole 1% cream in interdigital tinea pedis.口服特比萘芬（250毫克/天）一周与使用1%克霉唑乳膏治疗足趾间足癣四周的比较。
Br J Dermatol. 1998 Oct;139(4):675-8. doi: 10.1046/j.1365-2133.1998.02466.x.
8
Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis.口服特比萘芬与灰黄霉素治疗足跟型足癣的疗效比较
J Am Acad Dermatol. 1990 Oct;23(4 Pt 2):807-9. doi: 10.1016/0190-9622(90)70294-r.
9
Treatment of chronic moccasin-type tinea pedis with terbinafine: a double-blind, placebo-controlled trial.特比萘芬治疗慢性拖鞋型足癣：一项双盲、安慰剂对照试验。
J Am Acad Dermatol. 1990 Oct;23(4 Pt 2):804-7. doi: 10.1016/0190-9622(90)70293-q.
10
Substantivity of topically applied antifungals on dermatophytic toe webs.局部应用抗真菌药物对皮肤癣菌感染趾间的疗效
Cutis. 2001 May;67(5 Suppl):40-1.

引用本文的文献

1
[Topical terbinafine. Reduction of duration of therapy for tinea pedis].[外用特比萘芬。减少足癣治疗疗程]
Hautarzt. 2008 Dec;59(12):986-91. doi: 10.1007/s00105-008-1552-9.
2
Topical treatments for fungal infections of the skin and nails of the foot.足部皮肤和指甲真菌感染的局部治疗方法。
Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD001434. doi: 10.1002/14651858.CD001434.pub2.
3
Terbinafine. An update of its use in superficial mycoses.特比萘芬。其在浅表真菌病治疗中的应用进展
Drugs. 1999 Jul;58(1):179-202. doi: 10.2165/00003495-199958010-00018.
4
Pharmacoeconomic analysis of topical treatments for tinea infections.皮肤癣菌感染局部治疗的药物经济学分析
Pharmacoeconomics. 1995 Mar;7(3):251-67. doi: 10.2165/00019053-199507030-00009.
5
An overview of topical antifungal therapy in dermatomycoses. A North American perspective.皮肤真菌病的局部抗真菌治疗概述。北美视角。
Drugs. 1998 May;55(5):645-74. doi: 10.2165/00003495-199855050-00004.
6
Infectious disease in athletes.运动员的传染病
Med Clin North Am. 1994 Mar;78(2):389-412. doi: 10.1016/s0025-7125(16)30166-3.